Companies / India
Domestic Firms To See Strong Results
October 2006 | Company Finance AlertIndia's leading drugmakers are expected to record strong sales for the July-September quarter on the back of soaring demand for generic drugs on the domestic market. The rise in sales is partly due to the spread of diseases during the monsoon season, as well as the impact of foreign acquisitions and rising exports.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
